Authors' reply to: Inhibition of immune responses by Dasatinib may account for its different effects on neuroblastoma between in vitro and in vivo

Roberta Vitali, Giuseppe Raschellà

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)1250 -
JournalInternational Journal of Cancer
Issue number5
Publication statusPublished - 1 Sep 2010
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

Cite this